Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02588170
Recruitment Status : Active, not recruiting
First Posted : October 27, 2015
Last Update Posted : August 7, 2019
Sponsor:
Information provided by (Responsible Party):
Hutchison Medipharma Limited

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : March 31, 2019
Estimated Study Completion Date : September 2020